Silver needle thermal conduction therapy relieves pain in rats with myofascial pain syndrome.

Researchers investigated whether a specialized acupuncture technique called silver needle thermal conduction therapy could help relieve myofascial pain syndrome (MPS), a condition causing chronic muscle pain and tight trigger points. Scientists created an MPS model in rats by combining muscle impact with exercise fatigue, then treated the animals with heated silver needles for 14 days while comparing them to untreated rats.

The study found that rats with MPS showed increased pain sensitivity to both heat and pressure, visible muscle damage including fiber shrinkage and distortion, and elevated inflammation markers in their muscles. These rats also had imbalanced neurotransmitter levels in their spinal cords—specifically increased pain-signaling chemicals (CGRP and substance P) and decreased serotonin, which normally helps regulate pain.

After two weeks of silver needle thermal conduction therapy, the treated rats showed remarkable improvements. Their pain thresholds returned toward normal levels, meaning they could tolerate more heat and pressure without discomfort. The treatment reduced inflammatory chemicals in the muscles and helped restore normal neurotransmitter balance in the spinal cord. Muscle tissue also showed signs of healing.

For patients considering acupuncture for muscle pain and trigger points, this research suggests that thermal needle techniques may work through multiple mechanisms: reducing local muscle inflammation while also affecting how the nervous system processes pain signals. While animal studies don't always translate directly to human outcomes, these findings support traditional acupuncture approaches that use warmth combined with needle insertion for treating chronic muscle pain. Anyone interested in trying acupuncture for myofascial pain should seek treatment from a licensed acupuncturist with appropriate credentials and training.

This study evaluated silver needle thermal conduction therapy for myofascial pain syndrome using a rat model induced by combined impact and exercise fatigue. Animals received 14 days of treatment with assessment of thermal and mechanical pain thresholds, histological analysis via HE staining, and measurement of spinal neurotransmitters (CGRP, SP, 5-HT) through Western blot and immunohistochemistry, plus ELISA quantification of muscle inflammatory cytokines (IL-1β, TNF-α).

MPS rats demonstrated decreased pain thresholds, muscle fiber atrophy and deformation, elevated IL-1β and TNF-α in medial femoral muscle, increased spinal CGRP and SP expression, and decreased 5-HT levels. Silver needle thermal conduction therapy significantly reversed these pathological changes across all measured parameters.

Clinical implications: This research provides mechanistic evidence for thermal needle techniques in treating myofascial trigger points, suggesting dual action through peripheral anti-inflammatory effects and central neurotransmitter modulation. The findings support integrating thermal conduction methods when treating chronic myofascial pain presentations, particularly those with pronounced trigger point pathology.